The US Food and Drug Administration alerted clinicians, compounders, and patients about adverse events related to compounded ...

Existing advice for prescribing the weight loss drugs needs to be strengthened to minimize the risks from interactions, the ...

Especially in the summer, medical professionals should keep an eye out for cases of Lyme disease, anaplasmosis, babesiosis, ...

Europe's Committee for Medicinal Products for Human Use (CHMP) recommended the granting of marketing authorization for ...

Deuruxolitinib is the third treatment and third JAK inhibitor approved by the FDA for severe alopecia areata. Baricitinib ...

Researchers, clinicians, and patient advocates at a national meeting weighed in on efforts needed to accelerate research on ...

The effects of climate change are evident, but their consequences for mental health are not the same for everyone.

The European Medicines Agency said there were exceptional circumstances for approving Kayfanda to treat pruritus in patients ...

Leqembi's EU-wide marketing authorization was refused because the drug's effect on delaying cognitive decline does not ...

Approximately half of adults with idiopathic pulmonary arterial hypertension (IPAH) had nonplexiform vasculopathy ...

Home hemodialysis was linked to reduced cardiovascular risks vs peritoneal dialysis in a large study, but key caveats were ...

Extreme exposure to dry and hot weather conditions increased the plasma creatinine and cystatin C levels in older adults, ...